Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VALN Valneva > Detailed Quotes

VALN Valneva

Watchlist
13.402
-0.138-1.02%
Close  01/31 16:00 ET
High
13.790
Open
13.790
Turnover
75.73K
Low
13.402
Pre Close
13.540
Volume
5.61K
Market Cap
927.00M
P/E(TTM)
10.39
52wk High
40.700
Shares
69.17M
P/E(Static)
Loss
52wk Low
9.770
Float Cap
617.28M
Bid/Ask %
0.00%
Historical High
67.840
Shs Float
46.06M
Volume Ratio
0.70
Historical Low
9.770
Dividend TTM
--
Div Yield TTM
--
P/B
5.46
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
2.86%
Avg Price
13.508
Lot Size
1
Float Cap
617.28M
Bid/Ask %
0.00%
Historical High
67.840
Shs Float
46.06M
Volume Ratio
0.70
Historical Low
9.770
Dividend TTM
--
P/B
5.46
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
2.86%
Avg Price
13.508
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Valneva SE is a specialty vaccine company. The firm focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. It takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. It operates through the following segments: Commercialized products, COVID, Vaccine candidates and Technologies and services. The Commercialized products segment markets vaccines, currently IXIARO and DUKORAL vaccines, as well as third-party products. The COVID segment engages in the development, manufacturing and distribution related to COVID-19 vaccine candidate, VLA2001. The Vaccine candidates segment engages in proprietary research and development programs aiming to generate new approvable products in order to generate future cash flows from product sales or from commercialization through partnering with pharmaceutical companies, excluding COVID-19 vaccine candidate, VLA2001. The Technologies and services segment provides services and inventions at a commercialization stage. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.
CEO: Mr. Thomas Lingelbach
Market: NASDAQ
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist